Bodycote draws £1.6bn bids from CVC, Veritas

Bodycote Plc, a British industrial heat treatment specialist, has attracted competing takeover interest from private equity firms CVC Advisers Ltd. and Veritas Capital. Both suitors have submitted proposals that value the company at around £1.6 billion, creating a competitive situation for control of the business.

The indicative bids are structured as cash offers for Bodycote shares. CVC has proposed a price of 915 pence per share, while Veritas has tabled an offer at 914 pence per share. The one‑penny difference means CVC currently has the higher proposal, though both offers imply a similar overall valuation for the company.

Bodycote has indicated that it would be prepared to recommend either proposal to its shareholders on the financial terms currently outlined. This signals that the board views both approaches as potentially attractive for investors, subject to a firm intention to make an offer being confirmed on those terms.

The company is engaging with both CVC and Veritas as discussions continue. With two parties interested at similar valuations, shareholders face the prospect of a possible cash exit at a price in line with the indicated 915 pence and 914 pence per share levels, should a formal bid emerge from either or both bidders.

The presence of two competing private equity firms underscores the strategic interest in Bodycote’s industrial heat treatment operations. CVC’s proposal currently leads by a narrow margin on price, offering 915 pence per share compared with Veritas’s 914 pence per share.

Both proposals imply an enterprise value of roughly £1.6 billion for Bodycote, highlighting a broadly shared view of the company’s worth. The situation pits the two buyout firms against each other as they work to secure agreement with the board and, ultimately, attract shareholder support for any formal offer.

Bodycote has stated that it is talking to both bidders as the process develops. While the company has indicated a willingness to recommend either proposal on the current terms, there remains no certainty at this stage that a firm offer will be made by CVC, Veritas, or both.

Further progress will depend on whether the indicative proposals are converted into binding offers at or around the stated per‑share prices. Until then, the indicative valuations of approximately £1.6 billion and the marginal one‑penny price difference define the competitive landscape surrounding Bodycote’s potential change of ownership.